Congestive Heart Failure : (Record no. 59244)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 07185nam a22004933i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC3017722 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729124047.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2010 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781617619588 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781608766772 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC3017722 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL3017722 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr10654693 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)923653453 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC685.C53 -- C673 2010eb |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.1/29 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | García, Josia E. |
| 245 10 - TITLE STATEMENT | |
| Title | Congestive Heart Failure : |
| Remainder of title | Symptoms, Causes and Treatment. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Hauppauge : |
| Name of producer, publisher, distributor, manufacturer | Nova Science Publishers, Incorporated, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2010. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2010. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (244 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Cardiology Research and Clinical Developments |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- CONGESTIVE HEART FAILURE: SYMPTOMS, CAUSES AND TREATMENT -- CONGESTIVE HEART FAILURE: SYMPTOMS, CAUSES AND TREATMENT -- LIBRARY OF CONGRESS CATALOGING-IN-PUBLICATION DATA -- Contents -- Preface -- Chapter 1 MONITORING PULMONARY EDEMA IN CHF PATIENTS WITH A HYBRID BIO-IMPEDANCE APPROACH -- Abstract -- 1. Pulmonary Edema in CHF Patients - Origins and Measuring Techniques -- 2. The Bio-Impedance Approach in Measuring Pulmonary Edema -- 3. A Hybrid Bio-Impedance System for Diagnosing and Monitoring CHF Patients -- 3.1. Technical Design -- 3.1.1. Hardware design -- 3.1.2. Software design -- Lung resistivity estimation -- RR and QT interval calculation -- 3.2. Clinical Results -- 3.2.1. Baseline measurements -- 3.2.2. CHF patients' classification and long-term monitoring -- 3.2.3. Monitoring CHF patients under intravenous diuretics treatment -- 3.2.4. Correlation between bio-impedance measurements and X-ray radiographs -- 3.3. Monitoring CHF Patients at Home Via a Telemedicine Approach -- 4. Summary and Conclusions -- References -- Chapter 2 THE ASSOCIATION BETWEEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCKS AND HEART FAILURE: A REVIEW OF PATHOGENESIS AND MANAGEMENT -- Abstract -- 1. MADIT II and SCD-HeFT: Two Major Randomized Controlled Trials of Implantable Cardioverter-Defibrillator Therapy -- 2. Pathogenesis of Heart Failure in Patients with ICD Shocks -- The Effect of Shock: Appropriate and Inappropriate Shocks -- ICD Shocks and the Activation of Sympathetic Nervous System -- The Activation of Sympathetic Nervous System and the Psychiatric Consequences: Impact on Heart Failure Progression -- Management -- Patient Selection -- Optimal Medical Management of Heart Failure -- Device Programming -- Anti-Arrhythmic Medications, Including Amiodarone -- Management of Psychiatric Symptoms and Syndromes. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Organized Protocol for Review of Patients Receiving ICD Shocks -- Conclusion -- References -- Chapter 3 REVERSIBLE LEFT VENTRICULAR DYSFUNCTION: THE TAKOTSUBO SYNDROME -- Abstract -- Introduction -- Epidemiology -- Aetiology -- Clinical Features -- Diagnosis -- Laboratory Data -- Cardiac Biomarkers -- Stress Hormones -- Electrocardiography -- Echocardiography -- Coronary Angiography and Ventriculography -- Cardiovascular magnetic resonance imaging -- Myocardial Single Photon Emission Computed Tomography -- Endomyocardial Biopsies -- Pathophysiological Mechanisms -- Multivessel Epicardial Coronary Artery Spasm -- Coronary Microvascular Impairment -- Catecholamine Cardiotoxicity -- Therepeutic Options -- Prognosis -- Conclusion -- References -- Chapter 4 OXIDATIVE STRESS AND HEART FAILURE: STILL A VIABLE THERAPEUTIC TARGET? -- Abstract -- Introduction -- Sources of Oxidative Stress in Heart Failure -- Physiological Importance of Redox Signaling -- Implications for Stem Cell Therapy -- Redox-Smart Drug Design for Heart Failure -- Conclusion and Perspectives -- Acknowledgement -- References -- Chapter 5 SIMULATING CALCINEURIN-CENTERED CALCIUM SIGNALING NETWORK IN CARDIAC MYOCYTES -- Abstract -- 1. Introduction -- 2. Methods & -- Simulation Results -- 3. Discussions -- 4. Conclusion -- Acknowledgements -- References -- Appendix -- Chapter 6 RIGHT VENTRICULAR FAILURE IN CARDIAC SURGERY -- I. Introduction -- 2. Differences between the RV and LV -- 3. RV Function -- [Negative Intrathoracic Pressure in Early Diastole in the RV] -- Isolated RV model -- Interventricular interaction -- Diastolic Ventricular Interaction -- Systolic Ventricular Interaction -- Effects of LVAD Implantation on RV Function -- RV Afterload -- Effects of Global Ischemia on RV Function -- Treatment Strategy -- Conclusions -- References. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Chapter 7 PLASMA BRAIN NATRIURETIC PEPTIDE - AN INDEPENDENT PREDICTOR OF MORTALITY AND REHOSPITALIZATION IN CONGESTIVE HEART FAILURE - A META-ANALYSIS* -- Abstract -- Background -- Design -- Methods -- Results -- Conclusion -- Introduction -- Material and Methods -- Design -- Literature Search -- Validity Assessment -- Data Abstraction -- Analysis -- Results -- Discussion -- References -- Chapter 8 CONGESTIVE HEART FAILURE: DIFFERENT NON-INVASIVE DIAGNOSIS TECHNIQUES* -- Abstract -- 1. Introduction -- 1.1. Heart Failure -- 1.2. Heart Rate Variability (HRV) -- 2. Material -- 2.1. Data -- 2.2.1. Trial Group -- 2.1.2. Test Group -- 2.2. Pre-processing of RRI Data -- 3. Methods -- 3.1. Method 1: Statistical Signal Characterization -- 3.1.1. Hilbert Transform (HT) -- 3.1.2. Statistical Signal Characterization (SSC) -- 3.2. Method 2: Soft-Decision Wavelet Decomposition -- 3.2.1. Wavelet-decomposition of RRI signal -- 3.2.2. Estimation of Power Spectral Density -- 3.2.3. Implementation on MIT-Trial Data -- 3.3. Receiver Operating Characteristics -- 3.4. Method 3: Pattern Recognition -- 4. Results and Discussion -- 4.1. Results of Method 1: SSC -- 4.1.1. Results of Trial Data -- 4.1.2. Results of Test Data -- 4.1.3. Discussion on SSC results -- 4.1.4. Comparison with Other Studies -- 4.2. Results of Method 2: Soft-Decision Wavelet Decomposition -- 4.2.1. Comparison with FFT-Based Spectral Analysis -- 4.3. Results of Method 3: Pattern Recognition -- 4.3.1. Results on Trial and Test Data -- 4.3.2. Consistency of Results -- 4.3.3. Comparison with Other Techniques -- 5. Conclusion -- References -- Index. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Congestive heart failure. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Heart failure. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wright, Victor R. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | García, Josia E. |
| Title | Congestive Heart Failure: Symptoms, Causes and Treatment |
| Place, publisher, and date of publication | Hauppauge : Nova Science Publishers, Incorporated,c2010 |
| International Standard Book Number | 9781608766772 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Cardiology Research and Clinical Developments |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3017722">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3017722</a> |
| Public note | Click to View |
No items available.